Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins

Fertility and Sterility

Volumn 68, Issue 1, 1997, Pages 138-142

  Out, Henk J ^a   Driessen, Stefan G A J ^a   Mannaerts, Bernadette M J L ^a   Bennink, Herjan J T Coelingh ^a  

^a NV ORGANON   (Netherlands)

Author keywords

Follitropin beta; FSH; IVF; Meta analysis; Pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030793181     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81490-2     Document Type: Article

References (14)

1. Healy DL, Trounson AO, Andersen AN. Female infertility: causes and treatment. Lancet 1994;343:1539-44.
2. Olijve W, De Boer W, Mulders JWM, Van Wezenbeek PMGF. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod 1996;2:371-82.
3. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. A prospective, randomized, assessor-blind, multicenter study comparing recombinant and urinary follicle-stimulating hormone (Puregon vs Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-40.
4. Hedon B, Out HJ, Hugues JN, Gamier B, Cohen J, Lopes P, et al. Efficacy and safety of recombinant FSH (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilisation: a prospective, randomised, assessor-blind, multicentre trial. Hum Reprod 1995;10:3102-6.
5. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT. Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Hum Reprod Update 1996;2:162-71.
6. Duijkers IJM. Gonadotrophins, some basic and clinical aspects [dissertation]. University of Nijmegen (The Netherlands), 1995.
7. Out HJ, Olijve W, Coelingh Bennink HJT. The coming of wonders [letter]. Fertil Steril 1997;67:411-3.
8. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Stat Med 1991;10:1665-77.
9. Hughes EG, Sagle MA, Fedorkow DM, Koppel P van de, Daya S, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intra-fallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-96.
10. Daya S, Gunby J, Hughes EG, Collins JA, Sagle, MA. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil Steril 1995;64:347-54.
11. D'Agostinho RB, Weintraub M. Meta-analysis: a method for synthesizing research. Clin Pharmacol Ther 1995;58:605-16.
12. Shulman A, Ben-Nun I, Ghetler Y, Kaneti H, Shilon M, Beyth Y. Relationship between embryo morphology and implantation rate after in vitro fertilization treatment in conception cycles. Fertil Steril 1993;60:123-6.
13. Plancha CE, Albertini DF. Hormonal regulation of meiotic maturation in the hamster oocyte involves a cytoskeleton-mediated process. Biol Reprod 1994;51:852-64.
14. Matikainen T, de Leeuw R, Mannaerts B, Huhtaniemi I. Circulating bioactive and immunoreactive recombinant follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Fertil Steril 1994;61:62-9.